Complex Coronary Valvular and Vascular Cases Conference

 

Complex Coronary Valvular and Vascular Cases Conference
U

Newer P2 Y12 Inhibitors in ACS: One Year is a Must in Most!

By Complex Coronary Valvular and Vascular Cases Conference FEATURING Usman Baber
By Complex Coronary Valvular and Vascular Cases Conference FEATURING Usman Baber
45 views
July 29, 2018
Comments 0
Login to view comments. Click here to Login
Interventional Strategy: Points and Counterpoints
08:06

Stable CAD: Limited/No Benefit for PCI: ORBITA Trial

Complex Coronary Valvular and Vascular Cases Conference

D. Bhatt

130 views
09:03

Stable CAD: PCI Still Beneficial

Complex Coronary Valvular and Vascular Cases Conference

A. Kirtane

91 views
08:11

Severely Calcified Lesions; Atherectomy is a Must

Complex Coronary Valvular and Vascular Cases Conference

M. Reisman

11 views
08:18

Severely Calcified Lesions: Atherectomy Only as a Bailout

Complex Coronary Valvular and Vascular Cases Conference

9 views
06:54

DAPT Duration Post DES: 3-6 Months Will Suffice

Complex Coronary Valvular and Vascular Cases Conference

R. Waksman

351 views
10:06

DAPT Duration Post DES: Longer is Still an Option for Many!

Complex Coronary Valvular and Vascular Cases Conference

R. Mehran

60 views
05:58

Newer P2 Y12 Inhibitors in ACS: Losing Ground Due to Bleeding

Complex Coronary Valvular and Vascular Cases Conference

S. Rao

538 views
07:07

Newer P2 Y12 Inhibitors in ACS: One Year is a Must in Most!

Complex Coronary Valvular and Vascular Cases Conference

U. Baber

45 views
11:37

Interventional Strategy: Points and Counterpoints Panel Discussion

Complex Coronary Valvular and Vascular Cases Conference

8 views